Published in Gene Therapy Weekly, October 28th, 2004
With this funding, Perlegen will use next generation Affymetrix high density oligonucleotide array technology to genotype over 2.25 million unique single nucleotide polymorphisms (SNPs) in 270 samples from four populations being studied by the HapMap Project.
This represents over 600 million genotypes. Perlegen has been conducting high throughput genotyping at an unprecedented scale, having performed over 1.3 billion genotypes in just the first 6 months of 2004. The grant award...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.